ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects (Q34534715)

2 August 2017

ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects (English)

1 reference

2 August 2017

1 reference

Christopher M Iannuzzi

1

1 reference

2 August 2017

David P Atencio

2

1 reference

2 August 2017

Sheryl Green

3

1 reference

2 August 2017

Richard G Stock

4

1 reference

2 August 2017

Barry S Rosenstein

5

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

International Journal of Radiation Oncology Biology Physics

2 August 2017

1 reference

2 August 2017

52

1 reference

2 August 2017

3

1 reference

2 August 2017

606-613

1 reference

Cancer risk in ATM heterozygotes: a model of phenotypic and mechanistic differences between missense and truncating mutations

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902684-0

7 January 2021

Comparative human cellular radiosensitivity: II. The survival following gamma-irradiation of unstimulated (G0) T-lymphocytes, T-lymphocyte lines, lymphoblastoid cell lines and fibroblasts from normal donors, from ataxia-telangiectasia patients and f

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902684-0

7 January 2021

Incidence of cancer in 161 families affected by ataxia-telangiectasia

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902684-0

7 January 2021

Screening breast cancer patients for ATM mutations and polymorphisms by using denaturing high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902684-0

7 January 2021

Cellular localisation of the ataxia-telangiectasia (ATM) gene product and discrimination between mutated and normal forms

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902684-0

7 January 2021

Activation of the ATM kinase by ionizing radiation and phosphorylation of p53

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902684-0

7 January 2021

Enhanced phosphorylation of p53 by ATM in response to DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902684-0

7 January 2021

Characterization of ATM expression, localization, and associated DNA-dependent protein kinase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902684-0

7 January 2021

Analysis of Rad3 and Chk1 protein kinases defines different checkpoint responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902684-0

7 January 2021

Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902684-0

7 January 2021

Cancer risk and the ATM gene: a continuing debate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902684-0

7 January 2021

Ataxia-telangiectasia, cancer and the pathobiology of the ATM gene

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902684-0

7 January 2021

Enhanced radiation late effects and cellular radiation sensitivity in an ATM heterozygous breast cancer patient

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902684-0

7 January 2021

Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902684-0

7 January 2021

Testing for mutations of the ataxia telangiectasia gene in radiosensitive breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902684-0

7 January 2021

Absence of ATM truncations in patients with severe acute radiation reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902684-0

7 January 2021

Sequence analysis of the ATM gene in 20 patients with RTOG grade 3 or 4 acute and/or late tissue radiation side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902684-0

7 January 2021

Radiosensitivity of normal tissues in ataxia-telangiectasia heterozygotes

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902684-0

7 January 2021

Diversity ofATM gene mutations detected in patients with ataxia-telangiectasia

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902684-0

7 January 2021

Predominance of null mutations in ataxia-telangiectasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902684-0

7 January 2021

Ataxia-telangiectasia: identification and detection of founder-effect mutations in the ATM gene in ethnic populations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902684-0

7 January 2021

Identification of specific BRCA1 and BRCA2 variants by DHPLC

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902684-0

7 January 2021

High-resolution liquid chromatography of oligonucleotides on nonporous alkylated styrene-divinylbenzene copolymers

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902684-0

7 January 2021

Detection of single-nucleotide polymorphisms with the WAVE DNA fragment analysis system

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902684-0

7 January 2021

A highly sensitive, fast, and economical technique for mutation analysis in hereditary breast and ovarian cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902684-0

7 January 2021

Denaturing high performance liquid chromatography (DHPLC) used in the detection of germline and somatic mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902684-0

7 January 2021

Blind Analysis of Denaturing High-Performance Liquid Chromatography as a Tool for Mutation Detection

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902684-0

7 January 2021

Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902684-0

7 January 2021

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902684-0

7 January 2021

Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902684-0

7 January 2021

Relationship of the ataxia-telangiectasia protein ATM to phosphoinositide 3-kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902684-0

7 January 2021

A single ataxia telangiectasia gene with a product similar to PI-3 kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902684-0

7 January 2021

Silent mutation induces exon skipping of fibrillin-1 gene in Marfan syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902684-0

7 January 2021

10.1016/S0360-3016(01)02684-0

Identifiers

DOI

1 reference

2 August 2017

1 reference